Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers
Titel:
Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers
Auteur:
Jia, Jingquan Howard, Lauren Liu, Yingmiao Starr, Mark D. Brady, John C. Niedzwiecki, Donna Strickler, John H. Nixon, Andrew B.